QNRX
Quoin Pharmaceuticals, Ltd.Company with tickers: QNRX
CIK
1671502
CUSIP
74907L409
Shares Outstanding
2,008,418
13F Activity (30d)
17 filings
16 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $3,433,762 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | — | ||||
| Net Income | $-4,997,735 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |